Position in PHVS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$177,536,333
-$40,301 QoQ
Shares Held
6,284,472
-1.8% QoQ
Ownership
8.99%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PHVS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FMR LLC holds $49,674,888,413 across 352 Biotechnology names. PHVS ranks #60 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,579,166 | $4,823,808,652 | |
| 2 | ARGX |
Argenx SE
|
4,991,034 | $3,644,702,577 | |
| 3 | MRNA |
Moderna, Inc.
|
45,672,024 | $2,320,138,818 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
77,981,253 | $2,160,080,705 | |
| 5 | INSM |
INSMED Inc
|
13,160,167 | $2,151,950,504 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,556,637 | $1,843,957,869 | |
| 7 | RPRX |
Royalty Pharma plc
|
25,152,242 | $1,206,553,046 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,518,192 | $1,173,015,865 |
All Filings in PHVS
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $177,536,333 | 6,284,472 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $177,576,634 | 6,399,158 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $159,658,991 | 6,399,158 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $95,434,116 | 5,422,393 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $84,707,309 | 5,395,370 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $103,429,242 | 5,395,370 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $96,408,748 | 5,205,656 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $97,866,332 | 5,205,656 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $120,009,860 | 5,192,984 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $145,663,199 | 5,192,984 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $66,941,859 | 3,207,564 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $51,281,556 | 3,387,157 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $26,704,241 | 3,315,238 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $37,296,427 | 3,315,238 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $25,427,491 | 3,315,188 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $73,265,654 | 3,315,188 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $60,120,934 | 3,315,188 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $47,416,617 | 3,295,109 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $58,736,989 | 3,312,859 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $60,700,582 | 3,258,217 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $77,441,001 | 2,767,727 | Shares | Defined | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||